These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23222698)

  • 1. Current aspects of correction of neurohumoral system activity in patients after myocardial infarction.
    Kokorin VA; Spassky AA; Volov NA; Kokorin IA
    Pol Arch Med Wewn; 2012; 122 Suppl 1():47-54. PubMed ID: 23222698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurohumoral activation and remodeling after acute myocardial infarct and the effect of angiotensin-converting enzyme inhibitors].
    Dúbrava J; Cagán S
    Bratisl Lek Listy; 1993 Feb; 94(2):88-93. PubMed ID: 8102588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Remodeling after myocardial infarction--left ventricular dilation as potential therapeutic target].
    Maczewski M
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S483-8. PubMed ID: 20527404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure.
    Xu K; George I; Klotz S; Hay I; Xydas S; Zhang G; Cerami A; Wang J
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):506-12. PubMed ID: 20881614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular remodeling after myocardial infarction: past, present, and future.
    Tiyyagura SR; Pinney SP
    Mt Sinai J Med; 2006 Oct; 73(6):840-51. PubMed ID: 17117309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurohumoral systems escape control. Heart failure symptoms even once--long-term high risk prognosis].
    MMW Fortschr Med; 2005 Jul; 147(27-28):45. PubMed ID: 16041943
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurohormones, cytokines and programmed cell death in heart failure: a new paradigm for the remodeling heart.
    Valgimigli M; Curello S; Ceconi C; Agnoletti L; Comini L; Bachetti T; Merli E; Ferrari R
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):529-37. PubMed ID: 11916362
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Remodeling of the left ventricle after myocardial infarction].
    Droździak E; Piwowarska W
    Pol Merkur Lekarski; 1996 Oct; 1(4):219-22. PubMed ID: 9156927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of left ventricular hypertrophy with cardiovascular mortality.
    Sharpe N
    Int J Clin Pract Suppl; 2000 May; (110):16-22. PubMed ID: 10912303
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of left ventricular remodeling after reperfused acute myocardial infarction.
    Papadopoulos CE; Karvounis HI; Giannakoulas G; Karamitsos TD; Efthimiadis GK; Parharidis GE
    Am J Cardiol; 2007 Apr; 99(7):1024-5. PubMed ID: 17398206
    [No Abstract]   [Full Text] [Related]  

  • 17. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD; Udelson JE; Konstam MA
    Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
    Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early, selective growth hormone administration may ameliorate left ventricular remodeling after myocardial infarction.
    Mitsi AC; Hatzistergos K; Baltogiannis GG; Kolettis TM
    Med Hypotheses; 2005; 64(3):582-5. PubMed ID: 15617872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.